Thanks for the information Doc. I had to look up brachytherapy to understand what it means. That psa of 0.02
is out of this world. What is a psa of a young man say mid 20's? How long does the patient undergoing HIFU have to be fitted with a catherter after the procedure?
Here is a tidbit of the release:
"This agreement with Leica marks a significant milestone for Galena, and is a continuation of our focus on developing personalized and targeted medicines to advance cancer care," said Mark J. Ahn, Ph.D., President and Chief Executive Officer. "By partnering with Leica, we will be able to help pioneer personalized medicine for patients while ensuring the proper and accurate assessment of breast cancer patients considering participation in the NeuVax PRESENT trial."
Leica's Bond Oracle™ HER2 IHC System is an FDA cleared semi-quantitative immunohistochemical (IHC) assay to determine HER2 (Human Epidermal Growth Factor Receptor 2) oncoprotein status in breast cancer tissue processed for histological evaluation.
"The Leica Bond Oracle HER2 IHC System is validated as a fully-automated HER2 IHC test, and delivers the diagnostic confidence that comes with proven HER2 FISH concordance. We are pleased to be working with Galena Biopharma to potentially expand our indication for this product to HER2 negative patients," added Arnd Kaldowski, President of Leica Biosystems.
pretty cool and straight.
Sentiment: Strong Buy
The K man is a psychiatrist......ever hear of reverse psychology? His extrapolation of future events has a solid foundation......he is spot on. Never hurts to feel good about yourself, if you believe it ....who knows what will happen.
Gene, picked this up on the nectar board.
All study participants were treated with oral neratinib once daily.
16-week progression-free survival was 59% among women who had previously been treated with Herceptin and 78% among women with no prior Herceptin.
A response to treatment was observed in 24% of women who had been previously treated with Herceptin and 56% of women with no prior Herceptin.
The most common side effects of neratinib were diarrhea, nausea, vomiting, and fatigue.
The researchers concluded that neratinib is active and reasonably well tolerated among women with advanced, HER2-positive breast cancer. Neratinib will continue to be evaluated in breast cancer clinical trials.
It is oral and causes the same reactions as other chemotherapy drugs.
First listing on my home page at yahoo here in Cincinnati. This must be BIG news to block out all of the current events around the world. Will wonders never cease?
Sentiment: Strong Buy
Regarding the pipeline, management confirmed that the Phase II study of GALE 301 is enrolling better than expected. The NeuVax Phase III enrollment is also going well and the company expects to reach full enrollment of 700 patients by YE14. The protocol for the gastric cancer study with partner Dr. Reddy's (RDY-NC) in India is nearing completion. I like this little tidbit of info.
You are totally into this HIFU treatment/FDA approval goal.....congrats......I understand your excitement.....
it won't be long. Where it is going pps wise I do not know my goal is have enough shares to pay for the process if I need it. $25,000 is not that much, let me see, 5000 shares X$10 equals more than enough plus expenses.